Trust in our commitment to excellence, and embark on a journey towards a healthier, more vibrant you
In retrospect, these characteristics frequently reflect the physiological roles peptides evolved to perform
When weight loss is rapid, the flux of fatty acids and co-stored POPs into blood increases, acutely raising their serum concentrations and potentially increasing delivery to other organs.1,2 Because our bodys detoxification system is not efficient at clearing lipophilic chemical toxins, most of these re-mobilized lipophilic chemicals are redistributed into lipid-rich tissues, with only smaller percentages being effectively excreted through the bile-fecal route
These LBM findings have triggered an ongoing scientific debate, with critics worrying that such losses could result from reductions in skeletal muscle mass, thereby leading to frailty, particularly in older adults
not yet FDA-approved Saxenda SCALE weight loss / 8.0% mean body weight reduction at 56 weeks vs 2.6% placebo Retatrutide Phase 2 peak weight loss / 24.2% mean reduction at 48 weeks (12 mg dose) Saxenda adolescent approval / FDA-approved for ages 12+ with obesity (BMI 95th percentile) Retatrutide adolescent data / No pediatric data published as of 2025 GI side-effect profile / Both share nausea, vomiting, diarrhea
Diabetes 1996;45(8):1024-1029